Richards, Merrill & Peterson
ABBV icon

Richards, Merrill & Peterson’s AbbVie ABBV Stock Holding History

Richards, Merrill & Peterson’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.97M Buy
7,514
+111
+1% +$28.5K 0.6% 39
2026
Q2 		$1.86M Buy
7,403
+720
+11% +$155K 0.59% 41
2026
Q1 		$1.45M Buy
6,683
+96
+1% +$21.3K 0.53% 50
2025
Q4 		$1.5M Buy
6,587
+1,348
+26% +$307K 0.58% 43
2025
Q3 		$1.21M Buy
5,239
+182
+4% +$37.1K 0.52% 50
2025
Q2 		$939K Buy
5,057
+61
+1% +$11.3K 0.45% 62
2025
Q1 		$1.05M Buy
4,996
+22
+0.4% +$4.28K 0.54% 51
2024
Q4 		$884K Buy
+4,974
New +$915K 0.46% 57

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Richards, Merrill & Peterson's ABBV Position: Q3 2026 in Review

Richards, Merrill & Peterson increased its AbbVie (ABBV) stake by 1.5% in Q3 2026, buying an estimated $28.5K and bringing the position to 7,514 shares worth $1.97M. The position accounts for 0.6% of the portfolio, ranked #39.

Richards, Merrill & Peterson first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Richards, Merrill & Peterson held 7,514 shares of AbbVie worth $1.97M as of Q3 2026.
  • Richards, Merrill & Peterson bought 111 AbbVie shares in Q3 2026, an estimated $28.5K.
  • AbbVie made up 0.6% of Richards, Merrill & Peterson's portfolio in Q3 2026, its #39 holding.
  • Richards, Merrill & Peterson first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Richards, Merrill & Peterson's 13F filing for Q3 2026, filed 19 Oct 2026.